User:Mr. Ibrahem/Rolapitant

Rolapitant, sold under the brand name Varubi among others, is a medication used for chemotherapy-induced nausea and vomiting (CINV). It is more commonly used for nausea that occurs more than 24 hours after chemotherapy. It is used either by mouth or by injection into a vein.

Common side effects include hiccups, dizziness, headache, and tiredness. It interacts with St. John's wort. It works by blocking blocking NK1 receptor.

Rolapitant was approved for medical use in the United States in 2015. It was approved in Europe in 2017 but that approval was later withdrawn. In the United States it costs about 670 USD per dose.